Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.

DeJesus E, Herrera G, Teofilo E, Gerstoft J, Buendia CB, Brand JD, Brothers CH, Hernandez J, Castillo SA, Bonny T, Lanier ER, Scott TR; CNA30024 Study Team.

Clin Infect Dis. 2004 Oct 1;39(7):1038-46. Epub 2004 Sep 10.

PMID:
15472858
2.

Lamivudine/zidovudine/abacavir: triple combination tablet.

Ibbotson T, Perry CM.

Drugs. 2003;63(11):1089-98; discussion 1099-1100. Review.

PMID:
12749741
3.

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.

Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD005481. doi: 10.1002/14651858.CD005481.pub3. Review.

PMID:
23543540
4.

A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.

Shey M, Kongnyuy EJ, Shang J, Wiysonge CS.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005481. doi: 10.1002/14651858.CD005481.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD005481.

PMID:
19588374
5.

Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection.

Greig SL, Deeks ED.

Drugs. 2015 Apr;75(5):503-14. doi: 10.1007/s40265-015-0361-6. Review. Erratum in: Drugs. 2015 Apr;75(5):561.

PMID:
25698454
6.

A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.

Wolbach J, Capoccia K.

Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Review. No abstract available.

PMID:
10431297
7.

Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.

Bollen P, Reiss P, Schapiro J, Burger D.

Expert Opin Drug Saf. 2015;14(9):1457-72. doi: 10.1517/14740338.2015.1059818. Epub 2015 Jul 3. Review.

PMID:
26134478
8.

Review of NNRTIs: 'today and tomorrow'.

Katlama C.

Int J Clin Pract Suppl. 1999 Jun;103:16-20. Review.

PMID:
10622038
9.

Dolutegravir, abacavir and lamivudine as HIV therapy.

Fernandez-Montero JV, Barreiro P, Labarga P, De Mendoza C, Soriano V.

Expert Opin Pharmacother. 2014 May;15(7):1051-7. doi: 10.1517/14656566.2014.913023. Review.

PMID:
24754315
10.

Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.

Achenbach CJ, Scarsi KK, Murphy RL.

Adv Ther. 2010 Jan;27(1):1-16. doi: 10.1007/s12325-010-0006-9. Epub 2010 Mar 5. Review. Erratum in: Adv Ther. 2010 Feb;27(2):127.

11.

Efavirenz: enhancing the gold standard.

Arribas JR.

Int J STD AIDS. 2003 Oct;14 Suppl 1:6-14. Review.

PMID:
14617398
12.

Human genetic variability and HIV treatment response.

Haas DW.

Curr HIV/AIDS Rep. 2006 Jul;3(2):53-8. Review.

PMID:
16608660
13.

[Neurospychiatric symptoms in HIV infected patients and the role of efavirenz].

Bary M, David F, Gasnault J, Kerneis H, Linard F, Longuet P, Pelissolo A, Ravaux I.

Med Mal Infect. 2004 Oct;34(10):435-49. Review. French.

PMID:
15747468
14.

A manic episode associated with efavirenz therapy for HIV infection.

Shah MD, Balderson K.

AIDS. 2003 Jul 25;17(11):1713-4. Review. No abstract available.

PMID:
12853762
15.

An update on drug interactions with zidovudine.

Piscitelli SC, Polis MA.

AIDS Patient Care STDS. 1998 Sep;12(9):687-90. Review.

PMID:
15468442

Supplemental Content

Support Center